Gene · 8000
Papers1,687
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 1,687
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Dissecting the genetic heterogeneity of gastric cancer. | EBioMedicine | 2023 | 37209533 | PubTator, text mining | PubMed |
| Current literature review on the tumor immune micro-environment, its heterogeneity and future perspectives in treatment of advanced non-small cell lung cancer. | Transl Lung Cancer Res | 2023 | 37197639 | PubTator, text mining | PubMed |
| HSP70 Family in Cancer: Signaling Mechanisms and Therapeutic Advances. | Biomolecules | 2023 | 37189349 | PubTator, text mining | PubMed |
| CAR T cell-based immunotherapy and radiation therapy: potential, promises and risks. | Mol Cancer | 2023 | 37173782 | PubTator, text mining | PubMed |
| The new era of prostate-specific membrane antigen-directed immunotherapies and beyond in advanced prostate cancer: a review. | Ther Adv Med Oncol | 2023 | 37152424 | PubTator, text mining | PubMed |
| Deciphering and advancing CAR T-cell therapy with single-cell sequencing technologies. | Mol Cancer | 2023 | 37149643 | PubTator, text mining | PubMed |
| Human LY6 gene family: potential tumor-associated antigens and biomarkers of prognosis in uterine corpus endometrial carcinoma. | Oncotarget | 2023 | 37141412 | PubTator, text mining | PubMed |
| mRNA delivery in cancer immunotherapy. | Acta Pharm Sin B | 2023 | 37139419 | PubTator, text mining | PubMed |
| γδ-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer. | Sci Adv | 2023 | 37134157 | PubTator, text mining | PubMed |
| The Notch signaling pathway: a potential target for cancer immunotherapy. | J Hematol Oncol | 2023 | 37131214 | PubTator, text mining | PubMed |
| Spatial transcriptomics reveals the heterogeneity and FGG+CRP+ inflammatory cancer-associated fibroblasts replace islets in pancreatic ductal adenocarcinoma. | Front Oncol | 2023 | 37124494 | PubTator, text mining | PubMed |
| Up-Regulation of PSMA Expression In Vitro as Potential Application in Prostate Cancer Therapy. | Pharmaceuticals (Basel) | 2023 | 37111295 | PubTator, text mining | PubMed |
| The "Great Debate" at Immunotherapy Bridge 2022, Naples, November 30th-December 1st, 2022. | J Transl Med | 2023 | 37087493 | PubTator, text mining | PubMed |
| CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies. | Med Oncol | 2023 | 37083979 | PubTator, text mining | PubMed |
| Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression. | J Transl Med | 2023 | 37076857 | PubTator, text mining | PubMed |
| Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapy. | Front Med (Lausanne) | 2023 | 37064017 | PubTator, text mining | PubMed |
| Current status and progress of the development of prostate cancer vaccines. | J Cancer | 2023 | 37056394 | PubTator, text mining | PubMed |
| The role of integrin family in bone metabolism and tumor bone metastasis. | Cell Death Discov | 2023 | 37037822 | PubTator, text mining | PubMed |
| Single cell transcriptomic analysis of HPV16-infected epithelium identifies a keratinocyte subpopulation implicated in cancer. | Nat Commun | 2023 | 37031202 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8000/papers?page=10